SEC Form 4 · accession 0001615774-17-000042
Enumeral Biomedical Holdings, Inc. · ENUM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert L Van Nostrand
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2017 | A | 66,666 | $0.00 | A | 268,121 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock award granted by Enumeral Biomedical Holdings, Inc. (the "Company") pursuant to its non-employee director compensation program and the Company's 2014 Equity Incentive Plan, as amended. The restrictions on the shares underlying this award lapse in 4 quarterly installments on each of January 3, 2017, April 1, 2017, July 1, 2017, and October 1, 2017.